Dr. Mark Cleveland, vice president of new product development at Braintree Laboratories, Inc., said the partnership between Braintree Laboratories and the USA College of Medicine has been very successful. �We have been working with Dr. Di Palma since he was in the Air Force, and when he joined USA we followed him there,� he said. �Since then, USA has been involved in many key studies for our products.�
�Because of our close collaborative relationships, Braintree graciously made a capital campaign donation that will be used by the division of gastroenterology to support research and teaching activities,� he said.
Dr. Di Palma said he became involved with Braintree Laboratories in 1982 while researching a new product the company was developing. �This product became GoLYTLEY, which is used for colon cleansing for diagnostic and surgical procedures,� he said. �We have since collaborated in several clinical studies here at USA leading to the development of products such as NuLYTELY, HalfLYTLEY, MiraLax and SuPREP bowel prep kit.�
According to Dr. Cleveland, the cost for conducting pharmaceutical studies is steadily rising, making it difficult for smaller pharmaceutical companies to operate. �Partnering with academic medical institutions is critical for small companies,� he said. �We have found that working with academic institutions such as USA is very valuable.�
Dr. Cleveland said Braintree also values the partnership with USA because of its diverse patient population. �USA Health has a large patient base that can be drawn upon, which is an important factor the FDA looks for,� he said. �USA also does a fantastic job generating interest and recruiting patients to participate in studies.�
Braintree Laboratories is a privately held pharmaceutical company that was founded in 1982 in Braintree, Mass. They currently have four gastrointestinal lavages available in the United States Market. Click here to learn more.
0 Response to "USA Gastroenterology Receives $100,000 Donation"
Post a Comment